FDA Approves Orserdu and Expands Approval of Trodelvy®
On January 27, 2023, the FDA approved elacestrant (OrserduTM, Stemline Therapeutics, Inc.) and a companion diagnostic test for the treatment of people with...
Read More PAST ARTICLES
2023
SEARCH OUR SITE
for past articles or specific information.